MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
Open Access
- 6 February 2014
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 110 (6), 1614-1621
- https://doi.org/10.1038/bjc.2014.51
Abstract
Background: MicroRNAs (miRNAs) regulate the biological properties of colorectal cancer (CRC) cells and might serve as potential prognostic factors and therapeutic targets. In this study, we therefore globally profiled miRNAs associated with E-cadherin expression in CRC cells in an attempt to identify miRNAs that are associated with aggressive clinical course in CRC patients. Methods: Two CRC cell lines (Caco-2 and HRT-18) with different E-cadherin expression pattern were profiled for differences in abundance for more than 1000 human miRNAs using microarray technology. One of the most differentially expressed miRNAs, miR-200a was evaluated for its prognostic role in a cohort of 111 patients and independently validated in 217 patients of the Cancer Genome Atlas data set. To further characterise the biological role of miR-200a expression in CRC, in vitro miR-200a inhibition and overexpression were performed and the effects on cellular growth, apoptosis and epithelial–mesenchymal transition (EMT)-related gene expression were explored. Results: In situ hybridisation specifically localised miR-200a in CRC cells. In both cohorts, a low miR-200a expression was associated with poor survival (PPin vitro led to a significantly differential and converse expression of EMT-related genes (PP<0.05). Conclusions: In conclusion, our data suggest that low miR-200a expression is associated with poor prognosis in CRC patients. MiR-200a has a regulatory effect on EMT and is associated with cancer stem cell properties in CRC.Keywords
This publication has 29 references indexed in Scilit:
- Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer CellsGastroenterology, 2012
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasisMolecular Biology Reports, 2012
- Viewing Metastatic Colorectal Cancer as a Curable Chronic DiseaseAmerican Journal of Clinical Oncology, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- E-Cadherin and the Cytoskeletal Network in Colorectal Cancer Development and MetastasisCell Communication & Adhesion, 2011
- Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal CancerClinical Cancer Research, 2011
- Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesisOncogene, 2011
- MicroRNAs in body fluids—the mix of hormones and biomarkersNature Reviews Clinical Oncology, 2011
- Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatmentAnnals of Oncology, 2010